| |
| |
|
| Insider
Information: |
Huang Jane |
| Relationship: |
|
| City: |
Camana Bay, Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
211,342 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$24,688,484 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
211,342 |
|
|
| Total
Value |
$24,688,484 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -163.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beigene Ltd |
BGNE |
CMO, Hematology |
2021-12-14 |
160,055 |
2017-12-04 |
0 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
|
2024-04-04 |
51,287 |
2023-04-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
110 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-08-12 |
4 |
AS |
$132.47 |
$336,855 |
D/D |
(2,500) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-09-03 |
4 |
AS |
$144.41 |
$413,420 |
D/D |
(2,862) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-09-04 |
4 |
AS |
$129.40 |
$10,611 |
D/D |
(82) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-11-04 |
4 |
AS |
$189.08 |
$6,266,007 |
D/D |
(32,900) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-11-18 |
4 |
AS |
$192.24 |
$291,740 |
D/D |
(1,500) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-12-16 |
4 |
AS |
$160.07 |
$247,710 |
D/D |
(1,500) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-01-21 |
4 |
AS |
$170.09 |
$256,042 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-02-18 |
4 |
AS |
$170.01 |
$255,380 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-04-16 |
4 |
AS |
$160.00 |
$240,000 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-04-29 |
4 |
AS |
$162.30 |
$243,450 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-05-29 |
4 |
AS |
$162.63 |
$245,784 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-07-07 |
4 |
AS |
$200.00 |
$784,200 |
D/D |
(3,921) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-07-29 |
4 |
AS |
$208.35 |
$629,787 |
D/D |
(3,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-08-28 |
4 |
AS |
$240.15 |
$726,626 |
D/D |
(3,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-09-03 |
4 |
AS |
$232.25 |
$729,045 |
D/D |
(3,128) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-09-29 |
4 |
AS |
$274.42 |
$420,568 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-10-29 |
4 |
AS |
$299.88 |
$450,093 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-11-30 |
4 |
AS |
$256.00 |
$401,723 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-12-29 |
4 |
AS |
$244.90 |
$373,690 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-01-29 |
4 |
AS |
$318.48 |
$484,492 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-02-26 |
4 |
AS |
$315.62 |
$481,099 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-03-29 |
4 |
AS |
$321.94 |
$485,993 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-04-29 |
4 |
AS |
$350.25 |
$532,387 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-05-28 |
4 |
AS |
$352.85 |
$534,453 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-06-01 |
4 |
AS |
$362.64 |
$195,828 |
D/D |
(540) |
0 |
0 |
% |
|
110 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
